UBS Evidence Lab Survey Shows Hanesbrands (HBI) Could Benefit From Improved Champion Brand Awareness
Tweet Send to a Friend
UBS analyst Jay Sole reiterated a Neutral rating and $23.00 price target on Hanesbrands (NYSE: HBI) after an Evidence Lab ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
